<DOC>
	<DOCNO>NCT00677677</DOCNO>
	<brief_summary>Human papillomavirus ( HPV ) affect significant number transplant patient . In woman , human papillomavirus ( HPV ) cause genital wart , pre-cancerous area cervix , cervical cancer . In men , virus cause warts anal genital area . Men also sexually transmit virus partner . A patient organ transplant high risk infection well cancer lifelong immune suppressive medication . HPV vaccination effective prevention cervical cancer recommend female age 9-26 year Alberta Health Wellness Canadian National Advisory Committee Immunization ( NACI ) . However , well vaccine work transplant patient know . This study do look response immune system HPV vaccine men woman age 35 organ transplant . Men also include study potential get anal / genital wart transmit virus partner . The total duration study three year . Fifty female male solid organ transplant recipient ( lung , heart , liver , kidney , pancreas , small bowel combine organ transplant ) immunosuppression enrol study .</brief_summary>
	<brief_title>Safety Immunogenicity Human Papillomavirus ( HPV ) Vaccine Solid Organ Transplant Recipients</brief_title>
	<detailed_description>Cervical cancer affect significant proportion female population . In Canada , estimate 1,350 new diagnosis cervical cancer 2007 390 death [ 1 ] . Human papillomavirus ( HPV ) causative agent genital wart , cervical intraepithelial neoplasia , cervical cancer . In study , vaccine also give male , male develop anogenital wart transmit virus partner . HPV nonenveloped DNA virus contain early late gene . Although approximately 40 HPV type infect genital tract , cause majority disease . For example , cancer-causing HPV include HPV 16 whereas benign tumour cause HPV 6 [ 2 ] . HPV vaccine quadrivalent vaccine consist HPV type 6,11,16,18 . Types 16 18 implicated majority ( ~70 % ) cervical cancer least half CIN 2 3 lesion . Types 6 11 cause 90 % genital wart . The vaccine contain virus-like particle ( VLPs ) L1 proteins four serotypes adjuvanted aluminum hydroxyphosphate sulphate . The vaccine contain live virion cause HPV disease . It administer intramuscular injection three dose 0 , 2 month , 6 month [ 2 ] . HPV vaccination effective prevention high grade cervical lesion recommend female age 9-26 year Canadian National Advisory Committee Immunization ( NACI ) [ 3 ] . Although vaccine license female , male also develop anogenital wart transmit virus partner . Immunogenicity trial show similar response vaccine adolescent male compare female [ 15 ] . In addition , woman infect 1-3 four serotypes , vaccination appear prevent cervical lesion remain serotypes [ 16 ] . Therefore , although vaccine license woman ≤ 26 year old , may also applicable somewhat old woman may acquire four serotypes . Solid organ transplantation life-saving modality ; however , patient life-long immunosuppression put increase risk infection well cancer . Studies show high incidence HPV infection transplant recipient range 17.5-45 % [ 4-8 ] . An evaluation 105 renal transplant recipient show 17.5 % patient infected HPV [ 5 ] . Another study 39 renal transplant recipient screen HPV show presence HPV 30.7 % patient , primarily cervix [ 6 ] . Therefore , risk HPV infection estimate 17 time great renal transplant recipient match immunocompetent population . Ano-genital neoplasia , related HPV , 16-20 time common transplant recipient [ 5,6 ] . Yearly physical examination anogenital area annual Pap smear recommend transplant recipient [ 9 ] . However , data immunogenicity quadrivalent HPV vaccine solid organ transplant recipient formal recommendation vaccination transplant recipient exist . Given patient population uniquely susceptible HPV infection sequela , important vaccine immunogenicity study transplant recipient .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female Age ≥ 18 ≤ 35 Solid Organ Transplant ≥ 3 month posttransplant Outpatient status Unable comply protocol Previous HPV vaccination Anticoagulation ( precludes intramuscular injection ) Therapy acute rejection past 2 week Febrile illness past 2 week Active CMV infection History anogenital wart cervical intraepithelial neoplasia cervical cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Lung transplant</keyword>
	<keyword>Liver transplant</keyword>
	<keyword>Kidney transplant</keyword>
	<keyword>Pancreas transplant</keyword>
	<keyword>HPV</keyword>
	<keyword>Human Papillomavirus Quadrivalent Vaccine</keyword>
</DOC>